We are live on ! Find out more
ZYNE

Zynerba Pharmaceuticals, Inc
ZYNE

Delisted

ZYNE was delisted on the 10th of October, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of ZYNE yet.

ZYNE Hedge Fund Activity: Q2 2024 in Review

0 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Zynerba Pharmaceuticals, Inc (ZYNE) for Q2 2024, worth a combined $0 — down 100% from $16.2K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of ZYNE and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was B. Riley Wealth Advisors, exiting entirely with an estimated $16.2K sold.

  • 0 institutional investors held Zynerba Pharmaceuticals, Inc (ZYNE) as of Q2 2024, down from 1 in Q1 2024.
  • Funds reported $0 of Zynerba Pharmaceuticals, Inc stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Zynerba Pharmaceuticals, Inc positions in Q2 2024 and 1 closed out, a net change of -1 holder.
  • The largest Zynerba Pharmaceuticals, Inc seller in Q2 2024 was B. Riley Wealth Advisors, an estimated $16.2K sold.

Based on aggregated 13F filings for Q2 2024.